Cipla
BSE: 500087 | NSE: CIPLA | ISIN: INE059A01026 | SECTOR: Biotechnology & DrugsOpen
1,357.45High
1,401.00Low
1,352.45Prev Close
1,347.70P/E
-Median P/E
-P/B
-Median P/B
-Market Cap
1,130.35BVolume
87.33KVol. (20 day Avg.)
0PEG
-Div.Yield
-Bid
-Ask
-
Company Description
- Biotechnology & Drugs
BSE
500087NSE
CIPLAISIN
INE059A01026
Cipla Limited is an India-based company, which is primarily engaged in the business of pharmaceuticals. The Company operates through two segments: Pharmaceuticals and New ventures. The Pharmaceuticals segment is engaged in developing, manufacturing, selling, and distributing generic or branded generic medicines, as well as Active Pharmaceutical Ingredients (API). The New ventures segment includes the operations of the Company, a consumer healthcare, Biosimilars and specialty business. The Company's product portfolio spans complex generics, as well as drugs in the respiratory, anti-retroviral, urology, cardiology, anti-infective and central nervous system (CNS). The Company's geographical segments include India, the United States, South Africa, and Rest of the World. The Company has its network of manufacturing, trading and other incidental operations in India and International markets. The Company has approximately 47 manufacturing sites.
Company Officers
Umang Vohra
Global Chief Executive Officer, Managing Director, Executive DirectorAshish Adukia
Global Chief Financial OfficerAchin Gupta
Chief Executive Officer - One India BusinessPaul Miller
Chief Executive Officer - Cipla South Africa and Regional Head Africa and AccessNishant Saxena
Chief Executive Officer - Emerging Markets and EuropeArunesh Verma
Chief Executive Officer - North AmericaGeena Malhotra
Global Chief Technology OfficerPradeep Bhadauria
Global Chief Scientific OfficerRajendra Chopra
Compliance Officer, Company SecretarySwapn Malpani
Global Head Supply Chain